It supports glucose metabolism, making it beneficial for individuals with diabetes or those at risk
Its oral bioavailability is approximately 50%, and it reaches peak plasma concentration within 3 to 4 hours of dosing [1]
1300.83 kDa (id: XP_022026115.1, unknown protein/filaggrin-like, pI : 11.75, aa: 12581, Helianthus annuus )
Phytomedicine: Int J Phytotherapy Phytopharmacology
PMID: 29737803
Looking forward to seeing what steps the FDA takes next! Hayden Goldman, Director of Commercial Sales "The providers we work with have been clear: patient need is already there, and they are excited by the possibility of these peptides becoming available through licensed pharmacies that follow established quality standards, regulations, and guidelines